-+ 0.00%
-+ 0.00%
-+ 0.00%

Propanc Biopharma Q3 EPS $(0.28) Up From $(12.50) YoY

Benzinga·05/14/2026 21:33:01
Listen to the news
Propanc Biopharma (NASDAQ:PPCB) reported quarterly losses of $(0.28) per share. This is a 97.76 percent increase over losses of $(12.50) per share from the same period last year.